Skip to main content


  • Thursday, Nov 13th
    10:15 AM - 11:00 AM EST
    Beyond the Blood: Unlocking the Potential of Non-Blood-Based Cell-Free DNA in Cancer Care
    Location: 153ABC, Level 1
    Breakout Speaker: Christina Lockwood, PhD – University of Washington Medical Center
     CE: 1.5
  • Thursday, Nov 13th
    11:00 AM - 11:45 AM EST
    Revolutionizing Oncology: Advancements and Impact of Cell-Free DNA Testing in Precision Cancer Care
    Location: 153ABC, Level 1
    Breakout Speaker: Trevor Pugh, PhD, FACMG (he/him/his) – Princess Margaret Cancer Centre / Ontario Institute for Cancer Research
     CE: 1.5
  • Thursday, Nov 13th
    2:30 PM - 3:30 PM EST
    AMP Working Group: AMP/ASCO/CAP Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer Update & Revision
    Location: 153ABC, Level 1
    Working Group Speaker: Marilyn Li, MD (she/her/hers) – Children's Hospital of Philadelphia
    Working Group Panelist: Amir Behdad, MD, MBA (he/him/his) – Cleveland Clinic Florida
    Working Group Panelist: Scott A. Turner, PhD (he/him/his) – Virginia Commonwealth University
     CE: 1.0
  • Friday, Nov 14th
    10:15 AM - 10:45 AM EST
    Gene Fusions in Cancers: Challenges in Detection and Interpretation
    Location: 153ABC, Level 1
    Breakout Speaker: Angshumoy Roy, MD, PhD (he/him/his) – Baylor College of Medicine / Texas Children’s Hospital
     CE: 1.5
  • Friday, Nov 14th
    10:45 AM - 11:15 AM EST
    Current Standards for Classifying Fusion Oncogenicity and its Applications
    Location: 153ABC, Level 1
    Breakout Speaker: Jason Saliba, PhD (he/him/his) – Washington University School of Medicine in St. Louis
     CE: 1.5
  • Friday, Nov 14th
    11:15 AM - 11:45 AM EST
    Current Standards for Gene Fusion Nomenclature and Reporting
    Location: 153ABC, Level 1
    Breakout Speaker: Karen Tsuchiya, MD (she/her/hers) – Institute for Genomic Medicine/Nationwide Children's Hospital
     CE: 1.5
  • Friday, Nov 14th
    1:15 PM - 1:45 PM EST
    Experience of MayoComplete Organ Specific Panels - Including a Lung Cancer-Specific Panel
    Location: 153ABC, Level 1
    Breakout Speaker: Ying-Chun Lo, MD, PhD – Mayo Clinic
     CE: 1.5
  • Friday, Nov 14th
    1:45 PM - 2:15 PM EST
    Interpreting Virtual Panels from Broad Cancer Sequencing Data
    Location: 153ABC, Level 1
    Breakout Speaker: Melissa Tjota, MD, PhD – University of Chicago Medicine
     CE: 1.5
  • Friday, Nov 14th
    2:15 PM - 2:45 PM EST
    Clinical Implementation of Joint Exome/Transcriptome Sequencing
    Location: 153ABC, Level 1
    Breakout Speaker: Parth S. Shah (he/him/his) – Dartmouth Hitchcock and Medical Center
     CE: 1.5
  • Saturday, Nov 15th
    10:15 AM - 11:45 AM EST
    CAP/IASLC/AMP Guideline for the Molecular Testing of Lung Cancers for Treatment with Targeted Therapies Update & Revision
    Location: 153ABC, Level 1
    Breakout Speaker: Neal Lindeman, MD (he/him/his) – Weill Cornell Medicine/NewYork-Presbyterian Hospital
    Breakout Panelist: Sinchita Roy Chowdhuri, MD PhD – The University of Texas MD Anderson Cancer Center
    Breakout Panelist: Laura Tafe, MD (she/her/hers) – Dartmouth-Hitchcock Medical Center
     CE: 1.5
  • Saturday, Nov 15th
    1:15 PM - 2:15 PM EST
    AMP Working Group: Developing a More Patient-Friendly NGS Molecular Biomarker Report
    Location: 156ABC, Level 1
    Working Group Speaker: Jennifer Morrissette, PhD – Penn Medicine, Department of Pathology and Laboratory Medicine
    Working Group Panelist: Jane Gibson, PhD (she/her/hers) – Univ of Central Florida College of Medicine
    Working Group Panelist: Julie W. Hirschhorn, PhD (she/her/hers) – Geisinger
     CE: 1.0
  • Saturday, Nov 15th
    4:15 PM - 5:15 PM EST
    Plenary Solid Tumors
    Location: 153ABC, Level 1
    Program Committee Moderator: Arivarasan Karunamurthy – University of Pittsburgh Medical Center
    Program Committee Moderator: Fei Dong, MD – Stanford University
     CE: 1.0
  • Saturday, Nov 15th
    4:15 PM - 5:15 PM EST
    Leveraging RNA Sequencing for Splice Variant Discovery and Somatic Variant Prioritization in Precision Oncology
    Location: 153ABC, Level 1
    Plenary Speaker: Malachi Griffith, PhD (he/him/his) – Washington University
     CE: 1.0